Embria Health Sciences

The Discovery of a Novel Immune Modulatory Agent: EpiCor

October 16, 2006

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

CEDAR RAPIDS, Iowa—Alexander G. Schauss, Ph.D., FACN, lead scientist at AIBMR Life Sciences, will share the story behind EpiCor™, a breakthrough new immune health raw material with a surprising 64-year history. Learn how Cedar Rapids factory workers with unusually low sick leave rates led to the development of a new paradigm for immune health support. Understand the science that shows how this high-metabolite immunogen impacts natural killer (NK) cells (the “guard dogs” for the immune system), the mucosal immune barrier and human B cell activity. Discover why EpiCor is poised to change how consumers look to stay healthy and prevent illness.

The VendorWorks presentation will be given Friday, Oct. 20, from 11 to 11:50 a.m. at SupplySide West. For more information, visit www.embriahealth.com or Booth #7001.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like